Naftzger J. Christopher

Insider profile

Naftzger J. Christopher's trades of Arbutus Biopharma Corp's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2025-02-05 2025-02-04 PlS Planned sale
61,704 -21.2%
11.77
US$4,433,882
61,704 -21.2% 11.77 US$4,433,882
2025-02-04 2025-02-04 PrS Proposed sale
10,642
492.14
US$138,827
10,642 492.14 US$138,827